Empowering Patients' Lung Cancer Screening Uptake (Empower LCS)
Overview
- Phase
- Not Applicable
- Intervention
- Patient education
- Conditions
- Lung Cancer
- Sponsor
- University of California, Irvine
- Enrollment
- 79
- Locations
- 7
- Primary Endpoint
- Order of LDCT
- Status
- Completed
- Last Updated
- 2 months ago
Overview
Brief Summary
Lung cancer is the leading cause of cancer related mortality. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases mortality rate of lung cancer by 20%. Yet many patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test the effect of a a multi-level intervention on ordering LDCT within 6 months after patient enrollment. Our proposed intervention includes (1) Primary care provider notifications of patients' LCS eligibility; (2) patients' education ; (3) patients' referral to financial navigation resources; and (4) patients' reminder to discuss LCS during PCP visit.
Investigators
Gelareh Sadigh
Associate Professor
University of California, Irvine
Eligibility Criteria
Inclusion Criteria
- •Patients' Inclusion Criteria:
- •Aged 50- 80 years of age.
- •Be able to Speak English, Spanish, or Vietnamese
- •Must have a scheduled appointment with their Primary Care Providers within next one to three months.
- •The Scheduled PCP appointment is at any of the UCI Health primary care clinics in Orange County including two UCI federally qualified health centers
- •History of 20 pack year smoking history ( based on survey self report)
- •Current smoker or a former smoker who has quit smoking within the last 15 years (based on survey self report)
Exclusion Criteria
- •Prior history of lung cancer
- •chest CT for any reason in the last 12 months based on self-report and UCI EMR
- •history of Alzheimer's disease or dementia
- •Providers' Inclusion Criteria:
- •Primary Care Providers whose patients were enrolled in the Empower LCS trial.
- •Received notifications about the eligibility of their patients for lung cancer screening.
Arms & Interventions
Empower LCS
Patient will be given education material(addressing knowledge barriers); patients' referral to financial navigation resources (addressing health-related social risks); and patients' reminder to discuss LCS during PCP visit. Providers will also be notified of eligibility of their patients to receive LCS.
Intervention: Patient education
Empower LCS
Patient will be given education material(addressing knowledge barriers); patients' referral to financial navigation resources (addressing health-related social risks); and patients' reminder to discuss LCS during PCP visit. Providers will also be notified of eligibility of their patients to receive LCS.
Intervention: Referral to financial navigation resources
Empower LCS
Patient will be given education material(addressing knowledge barriers); patients' referral to financial navigation resources (addressing health-related social risks); and patients' reminder to discuss LCS during PCP visit. Providers will also be notified of eligibility of their patients to receive LCS.
Intervention: Patient Reminders
Empower LCS
Patient will be given education material(addressing knowledge barriers); patients' referral to financial navigation resources (addressing health-related social risks); and patients' reminder to discuss LCS during PCP visit. Providers will also be notified of eligibility of their patients to receive LCS.
Intervention: Provider Reminers
Outcomes
Primary Outcomes
Order of LDCT
Time Frame: within 6 months of enrollment
Number of participants who were ordered screening with Low Dose Computed Tomographyorder (LDCT) within 6 months after enrollment, assessed with self-reported surveys or EMR data extraction.
Secondary Outcomes
- Receipt of LDCT(Within 6 months of enrollment)
- LCS Discussion(within 6 months after enrollment)
- Perceived Risk of Lung Cancer(At 6 months post-enrollment)
- Perceived Severity of Lung Cancer(At 6 months post-enrollment)
- Perceived Benefit of Lung Cancer Screening(At 6 months post-enrollment)
- Perceived Barriers to Lung Cancer Screening(At 6 months post-enrollment)
- Perceived Self-efficacy for Lung Cancer Screening(At 6 months post-enrollment)
- Knowledge About Lung Cancer and Screening(At 6 months post-enrollment)
- Providers' Perceived Barriers to Lung Cancer Screening(Baseline)